FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new 4-(heterocycloalkyl)benzene-1,3-diol compounds described by general formula (I) presented below, wherein: R1, R2, R3 and R4 may be identical or different, and represent: - hydrogen,- C1-C4-alkyl radical,- hydroxymethyl, hydroxyethyl, - (C1-C4-alkoxy) carbonyl,- C1-C4-alkoxy,- hydroxyl, or R1 and R2 are bound to each other and to a carbon atom whereto attached to form a carbon cycle containing 5 or 6 carbon atoms, while R3 and R4 may be identical or different, and represent: - hydrogen, - C1-C4-alkyl radical, or R1 and R4 are bound to each other to form the chain -(CH2)2- or -(CH2)3-, while R2 and R3 may be identical or different, and represent: - hydrogen, - C1-C4-alkyl radical, X represents an oxygen atom or a sulphur atom, Y represents hydrogen, a chlorine atom or a fluorine atom, the value of m may represent 1 or 2, while the value of n may represent 0 or 1, and provided n=0, then m=1 or 2, and provided n=1, then m=1, as well as to salts of the compounds of general formula (I) and to their isomer and enantiomer forms.
EFFECT: invention relates to the use of these compounds in pharmaceutical or cosmetic compositions for the use in treating or preventing pigmentary disorders.
7 cl, 2 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
NOVEL BENZODIOXOLS | 2003 |
|
RU2304580C2 |
NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN HUMAN TREATMENT AND IN COSMETICS | 2009 |
|
RU2499794C2 |
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2013 |
|
RU2607081C2 |
NOVEL DERIVATIVE OF PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYLSULPHONAMIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH HAS INHIBITION ACTIVITY WITH RESPECT TO RAF-KINASE, CONTAINING CLAIMED COMPOUND AS ACTIVE INGREDIENT | 2011 |
|
RU2550038C2 |
HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2016 |
|
RU2710743C2 |
NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | 2005 |
|
RU2394021C2 |
TRIAZINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES | 2015 |
|
RU2692789C2 |
CONDENSED BENZAMIDE DERIVATIVE AND INHIBITOR OF VANILLOID RECEPTOR TYPE 1 ACTIVITY (VRI) | 2005 |
|
RU2392278C2 |
Authors
Dates
2013-05-20—Published
2009-12-02—Filed